Literature DB >> 953646

Mountain sickness, retinal haemorrhages, and acclimatisation on Mount Everest in 1975.

C Clarke, J Duff.   

Abstract

During the 1975 British Everest Expedition, which made the first ascent of the south-west face, observations were made in relation to mountain sickness and the appearance of retinal changes. Two Sherpas with cerebral oedema and one Briton with pulmonary oedema were treated. Retinal haemorrhages occurred in four out of six Britons who were newcomers to altitudes over 6000 m (19 685 ft) but in only two out of 14 Britons who had previously visited these altitudes. Intraocular pressures during ascent to 6000 m were within normal limits. The relevance of the ocular findings to acclimatisation in previous years was examined, the results supporting the hypothesis of a "carry-over" effect from previous visits to high altitude.

Entities:  

Mesh:

Year:  1976        PMID: 953646      PMCID: PMC1687995          DOI: 10.1136/bmj.2.6034.495

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  6 in total

1.  Retinal changes in Himalayan climbers.

Authors:  D Rennie; J Morrissey
Journal:  Arch Ophthalmol       Date:  1975-06

2.  High altitude stress and retinal hemorrhage: relation to vascular headache mechanisms.

Authors:  G A Schumacher; J H Petajan
Journal:  Arch Environ Health       Date:  1975-05

3.  High altitude retinopathy in mountain climbers.

Authors:  W T Shults; K C Swan
Journal:  Arch Ophthalmol       Date:  1975-06

4.  High altitude retinal hemorrhage.

Authors:  M Wiedman
Journal:  Arch Ophthalmol       Date:  1975-06

5.  Retinal hemorrhage at high altitude.

Authors:  R Frayser; C S Houston; A C Bryan; I D Rennie; G Gray
Journal:  N Engl J Med       Date:  1970-05-21       Impact factor: 91.245

6.  Cerebral form of high-altitude illness.

Authors:  C S Houston; J Dickinson
Journal:  Lancet       Date:  1975-10-18       Impact factor: 79.321

  6 in total
  13 in total

1.  Intraocular pressure changes during high-altitude acclimatization.

Authors:  Mitrofanis Pavlidis; Tobias Stupp; Ilias Georgalas; Evi Georgiadou; Michail Moschos; Solon Thanos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-13       Impact factor: 3.117

2.  Acute mountain sickness.

Authors:  A D Wright; R F Fletcher
Journal:  Postgrad Med J       Date:  1987-03       Impact factor: 2.401

3.  Asymptomatic retinal haemorrhage is common at altitude.

Authors:  R E MacLaren
Journal:  BMJ       Date:  1995-09-23

Review 4.  Medicine and mechanisms in altitude sickness. Recommendations.

Authors:  J H Coote
Journal:  Sports Med       Date:  1995-09       Impact factor: 11.136

5.  Severe acute mountain sickness.

Authors:  J G Dickinson
Journal:  Postgrad Med J       Date:  1979-07       Impact factor: 2.401

Review 6.  Acute mountain sickness: medical problems associated with acute and subacute exposure to hypobaric hypoxia.

Authors:  C Clarke
Journal:  Postgrad Med J       Date:  2006-11       Impact factor: 2.401

7.  High altitude medical problems.

Authors:  H N Hultgren
Journal:  West J Med       Date:  1979-07

8.  The relation between intraocular pressure change and plasma natriuretic peptide under simulated hypobaric conditions.

Authors:  Remzi Karadag; Ahmet Sen; Nilgun Yildirim; Hikmet Basmak; Haydar Golemez; Erdinc Cakir; Ahmet Akin
Journal:  Indian J Ophthalmol       Date:  2010 May-Jun       Impact factor: 1.848

9.  Intraocular pressure after exposure to moderate altitude.

Authors:  Hossein Nazari; Naveed Nilforushan; Ahad Sedaghat; Reza Soudi; Alireza Irani; Arjang Gordiz; Shima Hatamkhani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-09       Impact factor: 3.117

10.  Delayed appearance of high altitude retinal hemorrhages.

Authors:  Daniel Barthelmes; Martina M Bosch; Tobias M Merz; Benno L Petrig; Frederic Truffer; Konrad E Bloch; Timothy A Holmes; Philippe Cattin; Urs Hefti; Miriam Sellner; Florian K P Sutter; Marco Maggiorini; Klara Landau
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.